Advertisement

Index by Author

October 2000; 23 (10)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Abraira, C

    • Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators. Diabetes Care October 2000 23:1478-1485; doi:10.2337/diacare.23.10.1478

  2. Appelman, A M

    • Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia. Diabetes Care October 2000 23:1467-1471; doi:10.2337/diacare.23.10.1467

  3. Arboix, A

    • Diabetes is an independent risk factor for in-hospital mortality from acute spontaneous intracerebral hemorrhage. Diabetes Care October 2000 23:1527-1532; doi:10.2337/diacare.23.10.1527

B

  1. Belfiore, F

    • Insulin sensitivity indexes calculated from oral glucose tolerance test data. Diabetes Care October 2000 23:1595-1596; doi:10.2337/diacare.23.10.1595

  2. Bertocci, L A

    • Skeletal muscle morphology and exercise response in congenital generalized lipodystrophy. Diabetes Care October 2000 23:1545-1550; doi:10.2337/diacare.23.10.1545

  3. Bloomgarden, Z T

    • Obesity and diabetes. Diabetes Care October 2000 23:1584-1590; doi:10.2337/diacare.23.10.1584

  4. Blüher, M

    • Improvement of insulin sensitivity after adrenalectomy in patients with pheochromocytoma. Diabetes Care October 2000 23:1591-1592; doi:10.2337/diacare.23.10.1591

  5. Byers, T

    • Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care October 2000 23:1499-1504; doi:10.2337/diacare.23.10.1499

C

  1. Canga, N

    • Intervention study for smoking cessation in diabetic patients: a randomized controlled trial in both clinical and primary care settings. Diabetes Care October 2000 23:1455-1460; doi:10.2337/diacare.23.10.1455

  2. Cianciulli, D

    • What degree of maternal metabolic control in women with type 1 diabetes is associated with normal body size and proportions in full-term infants? Diabetes Care October 2000 23:1494-1498; doi:10.2337/diacare.23.10.1494

  3. Cioni, R

    • What degree of maternal metabolic control in women with type 1 diabetes is associated with normal body size and proportions in full-term infants? Diabetes Care October 2000 23:1494-1498; doi:10.2337/diacare.23.10.1494

  4. Coburn, J W

    • Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators. Diabetes Care October 2000 23:1478-1485; doi:10.2337/diacare.23.10.1478

  5. Collins, P

    • Dietary unsaturated fatty acids in type 2 diabetes: higher levels of postprandial lipoprotein on a linoleic acid-rich sunflower oil diet compared with an oleic acid-rich olive oil diet. Diabetes Care October 2000 23:1472-1477; doi:10.2337/diacare.23.10.1472

  6. Colwell, J A

    • Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators. Diabetes Care October 2000 23:1478-1485; doi:10.2337/diacare.23.10.1478

  7. Comstock, J P

    • Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators. Diabetes Care October 2000 23:1478-1485; doi:10.2337/diacare.23.10.1478

  8. Connell, C M

    • Effect of adults' self-regulation of diabetes on quality-of-life outcomes. Diabetes Care October 2000 23:1511-1515; doi:10.2337/diacare.23.10.1511

D

  1. D'Episcopo, L

    • Long-term dietary treatment with increased amounts of fiber-rich low-glycemic index natural foods improves blood glucose control and reduces the number of hypoglycemic events in type 1 diabetic patients. Diabetes Care October 2000 23:1461-1466; doi:10.2337/diacare.23.10.1461

  2. Davis, J L

    • Use of sibutramine hydrochloride monohydrate in the treatment of the painful peripheral neuropathy of diabetes. Diabetes Care October 2000 23:1594-1595; doi:10.2337/diacare.23.10.1594

  3. De Irala, J

    • Intervention study for smoking cessation in diabetic patients: a randomized controlled trial in both clinical and primary care settings. Diabetes Care October 2000 23:1455-1460; doi:10.2337/diacare.23.10.1455

  4. Duaso, M J

    • Intervention study for smoking cessation in diabetic patients: a randomized controlled trial in both clinical and primary care settings. Diabetes Care October 2000 23:1455-1460; doi:10.2337/diacare.23.10.1455

E

  1. Emanuele, N V

    • Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators. Diabetes Care October 2000 23:1478-1485; doi:10.2337/diacare.23.10.1478

  2. Engelgau, M M

    • Screening for type 2 diabetes. Diabetes Care October 2000 23:1563-1580; doi:10.2337/diacare.23.10.1563

  3. Erkelens, D W

    • Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia. Diabetes Care October 2000 23:1467-1471; doi:10.2337/diacare.23.10.1467

F

  1. Ferrer, A

    • Intervention study for smoking cessation in diabetic patients: a randomized controlled trial in both clinical and primary care settings. Diabetes Care October 2000 23:1455-1460; doi:10.2337/diacare.23.10.1455

  2. Fitzgerald, J T

    • Effect of adults' self-regulation of diabetes on quality-of-life outcomes. Diabetes Care October 2000 23:1511-1515; doi:10.2337/diacare.23.10.1511

  3. Flanders, D

    • Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care October 2000 23:1499-1504; doi:10.2337/diacare.23.10.1499

G

  1. García-Eroles, L

    • Diabetes is an independent risk factor for in-hospital mortality from acute spontaneous intracerebral hemorrhage. Diabetes Care October 2000 23:1527-1532; doi:10.2337/diacare.23.10.1527

  2. Garg, A

    • Skeletal muscle morphology and exercise response in congenital generalized lipodystrophy. Diabetes Care October 2000 23:1545-1550; doi:10.2337/diacare.23.10.1545

  3. Geckle, M O

    • Circumscribed cognitive dysfunction in middle-aged adults with type 2 diabetes. Diabetes Care October 2000 23:1486-1493; doi:10.2337/diacare.23.10.1486

  4. Giacco, A

    • Long-term dietary treatment with increased amounts of fiber-rich low-glycemic index natural foods improves blood glucose control and reduces the number of hypoglycemic events in type 1 diabetic patients. Diabetes Care October 2000 23:1461-1466; doi:10.2337/diacare.23.10.1461

  5. Giacco, R

    • Long-term dietary treatment with increased amounts of fiber-rich low-glycemic index natural foods improves blood glucose control and reduces the number of hypoglycemic events in type 1 diabetic patients. Diabetes Care October 2000 23:1461-1466; doi:10.2337/diacare.23.10.1461

  6. Glasgow, R E

    • Giving smoking cessation the attention that it deserves. Diabetes Care October 2000 23:1453-1454; doi:10.2337/diacare.23.10.1453

H

  1. Hamada, Y

    • Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients. Diabetes Care October 2000 23:1539-1544; doi:10.2337/diacare.23.10.1539

  2. Hamasaki, A

    • Association of autoimmune pancreatitis and type 1 diabetes: autoimmune exocrinopathy and endocrinopathy of the pancreas. Diabetes Care October 2000 23:1592-1594; doi:10.2337/diacare.23.10.1592

  3. Henderson, W G

    • Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators. Diabetes Care October 2000 23:1478-1485; doi:10.2337/diacare.23.10.1478

  4. Herman, W H

    • Screening for type 2 diabetes. Diabetes Care October 2000 23:1563-1580; doi:10.2337/diacare.23.10.1563

  5. Hickey, T

    • Effect of adults' self-regulation of diabetes on quality-of-life outcomes. Diabetes Care October 2000 23:1511-1515; doi:10.2337/diacare.23.10.1511

  6. Horiuchi, S

    • Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients. Diabetes Care October 2000 23:1539-1544; doi:10.2337/diacare.23.10.1539

  7. Hotta, N

    • Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients. Diabetes Care October 2000 23:1539-1544; doi:10.2337/diacare.23.10.1539

I

  1. Ingersoll-Dayton, B

    • Effect of adults' self-regulation of diabetes on quality-of-life outcomes. Diabetes Care October 2000 23:1511-1515; doi:10.2337/diacare.23.10.1511

  2. Inoue, F

    • Association of autoimmune pancreatitis and type 1 diabetes: autoimmune exocrinopathy and endocrinopathy of the pancreas. Diabetes Care October 2000 23:1592-1594; doi:10.2337/diacare.23.10.1592

K

  1. Karhapää, P

    • Variants in the hepatocyte nuclear factor-1alpha and -4alpha genes in Finnish and Chinese subjects with late-onset type 2 diabetes. Diabetes Care October 2000 23:1533-1538; doi:10.2337/diacare.23.10.1533

  2. Kärkkäinen, P

    • Variants in the hepatocyte nuclear factor-1alpha and -4alpha genes in Finnish and Chinese subjects with late-onset type 2 diabetes. Diabetes Care October 2000 23:1533-1538; doi:10.2337/diacare.23.10.1533

  3. Karvonen, M

    • Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care October 2000 23:1516-1526; doi:10.2337/diacare.23.10.1516

  4. Kasuya, Y

    • Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients. Diabetes Care October 2000 23:1539-1544; doi:10.2337/diacare.23.10.1539

  5. Kato, K

    • Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients. Diabetes Care October 2000 23:1539-1544; doi:10.2337/diacare.23.10.1539

  6. Kekäläinen, P

    • Variants in the hepatocyte nuclear factor-1alpha and -4alpha genes in Finnish and Chinese subjects with late-onset type 2 diabetes. Diabetes Care October 2000 23:1533-1538; doi:10.2337/diacare.23.10.1533

  7. Klem, L

    • Effect of adults' self-regulation of diabetes on quality-of-life outcomes. Diabetes Care October 2000 23:1511-1515; doi:10.2337/diacare.23.10.1511

  8. Komori, T

    • Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients. Diabetes Care October 2000 23:1539-1544; doi:10.2337/diacare.23.10.1539

  9. Kuusisto, J

    • Variants in the hepatocyte nuclear factor-1alpha and -4alpha genes in Finnish and Chinese subjects with late-onset type 2 diabetes. Diabetes Care October 2000 23:1533-1538; doi:10.2337/diacare.23.10.1533

L

  1. Laakso, M

    • Variants in the hepatocyte nuclear factor-1alpha and -4alpha genes in Finnish and Chinese subjects with late-onset type 2 diabetes. Diabetes Care October 2000 23:1533-1538; doi:10.2337/diacare.23.10.1533

  2. LaPorte, R

    • Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care October 2000 23:1516-1526; doi:10.2337/diacare.23.10.1516

  3. Lasorella, G

    • Long-term dietary treatment with increased amounts of fiber-rich low-glycemic index natural foods improves blood glucose control and reduces the number of hypoglycemic events in type 1 diabetic patients. Diabetes Care October 2000 23:1461-1466; doi:10.2337/diacare.23.10.1461

  4. La Torre, P

    • What degree of maternal metabolic control in women with type 1 diabetes is associated with normal body size and proportions in full-term infants? Diabetes Care October 2000 23:1494-1498; doi:10.2337/diacare.23.10.1494

  5. Lavery, L A

    • Systemic hyperbaric oxygen therapy: lower-extremity wound healing and the diabetic foot. Diabetes Care October 2000 23:1551-1555; doi:10.2337/diacare.23.10.1551

  6. Lester, A

    • Dental and other health care visits among U.S. adults with diabetes. Diabetes Care October 2000 23:1505-1510; doi:10.2337/diacare.23.10.1505

  7. Levin, S R

    • Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators. Diabetes Care October 2000 23:1478-1485; doi:10.2337/diacare.23.10.1478

  8. Libman, I

    • Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care October 2000 23:1516-1526; doi:10.2337/diacare.23.10.1516

  9. Liebminger, A

    • HbA1c determination and predicting the clinical status of diabetic patients. Diabetes Care October 2000 23:1597; doi:10.2337/diacare.23.10.1597

  10. Lipp, R W

    • HbA1c determination and predicting the clinical status of diabetic patients. Diabetes Care October 2000 23:1597; doi:10.2337/diacare.23.10.1597

M

  1. Madigan, C

    • Dietary unsaturated fatty acids in type 2 diabetes: higher levels of postprandial lipoprotein on a linoleic acid-rich sunflower oil diet compared with an oleic acid-rich olive oil diet. Diabetes Care October 2000 23:1472-1477; doi:10.2337/diacare.23.10.1472

  2. Martínez-González, M A

    • Intervention study for smoking cessation in diabetic patients: a randomized controlled trial in both clinical and primary care settings. Diabetes Care October 2000 23:1455-1460; doi:10.2337/diacare.23.10.1455

  3. Massons, J

    • Diabetes is an independent risk factor for in-hospital mortality from acute spontaneous intracerebral hemorrhage. Diabetes Care October 2000 23:1527-1532; doi:10.2337/diacare.23.10.1527

  4. Mecacci, F

    • What degree of maternal metabolic control in women with type 1 diabetes is associated with normal body size and proportions in full-term infants? Diabetes Care October 2000 23:1494-1498; doi:10.2337/diacare.23.10.1494

  5. Mello, G

    • What degree of maternal metabolic control in women with type 1 diabetes is associated with normal body size and proportions in full-term infants? Diabetes Care October 2000 23:1494-1498; doi:10.2337/diacare.23.10.1494

  6. Miettinen, R

    • Variants in the hepatocyte nuclear factor-1alpha and -4alpha genes in Finnish and Chinese subjects with late-onset type 2 diabetes. Diabetes Care October 2000 23:1533-1538; doi:10.2337/diacare.23.10.1533

  7. Miyake, N

    • Association of autoimmune pancreatitis and type 1 diabetes: autoimmune exocrinopathy and endocrinopathy of the pancreas. Diabetes Care October 2000 23:1592-1594; doi:10.2337/diacare.23.10.1592

  8. Mizumoto, T

    • Association of autoimmune pancreatitis and type 1 diabetes: autoimmune exocrinopathy and endocrinopathy of the pancreas. Diabetes Care October 2000 23:1592-1594; doi:10.2337/diacare.23.10.1592

  9. Moltchanova, E

    • Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care October 2000 23:1516-1526; doi:10.2337/diacare.23.10.1516

  10. Mykkänen, L

    • Variants in the hepatocyte nuclear factor-1alpha and -4alpha genes in Finnish and Chinese subjects with late-onset type 2 diabetes. Diabetes Care October 2000 23:1533-1538; doi:10.2337/diacare.23.10.1533

N

  1. Nagai, R

    • Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients. Diabetes Care October 2000 23:1539-1544; doi:10.2337/diacare.23.10.1539

  2. Nakamura, J

    • Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients. Diabetes Care October 2000 23:1539-1544; doi:10.2337/diacare.23.10.1539

  3. Narayan, K M

    • Screening for type 2 diabetes. Diabetes Care October 2000 23:1563-1580; doi:10.2337/diacare.23.10.1563

  4. Naruse, K

    • Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients. Diabetes Care October 2000 23:1539-1544; doi:10.2337/diacare.23.10.1539

  5. Nishida, O

    • Association of autoimmune pancreatitis and type 1 diabetes: autoimmune exocrinopathy and endocrinopathy of the pancreas. Diabetes Care October 2000 23:1592-1594; doi:10.2337/diacare.23.10.1592

  6. Niskanen, L

    • Variants in the hepatocyte nuclear factor-1alpha and -4alpha genes in Finnish and Chinese subjects with late-onset type 2 diabetes. Diabetes Care October 2000 23:1533-1538; doi:10.2337/diacare.23.10.1533

  7. Nouwen, A

    • A review of the relationship between depression and diabetes in adults: is there a link? Diabetes Care October 2000 23:1556-1562; doi:10.2337/diacare.23.10.1556

  8. Nuttall, F Q

    • Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators. Diabetes Care October 2000 23:1478-1485; doi:10.2337/diacare.23.10.1478

O

  1. Okamoto, M

    • Association of autoimmune pancreatitis and type 1 diabetes: autoimmune exocrinopathy and endocrinopathy of the pancreas. Diabetes Care October 2000 23:1592-1594; doi:10.2337/diacare.23.10.1592

  2. Oliveres, M

    • Diabetes is an independent risk factor for in-hospital mortality from acute spontaneous intracerebral hemorrhage. Diabetes Care October 2000 23:1527-1532; doi:10.2337/diacare.23.10.1527

  3. Owens, D

    • Dietary unsaturated fatty acids in type 2 diabetes: higher levels of postprandial lipoprotein on a linoleic acid-rich sunflower oil diet compared with an oleic acid-rich olive oil diet. Diabetes Care October 2000 23:1472-1477; doi:10.2337/diacare.23.10.1472

P

  1. Pamuk, E

    • Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care October 2000 23:1499-1504; doi:10.2337/diacare.23.10.1499

  2. Parillo, M

    • Long-term dietary treatment with increased amounts of fiber-rich low-glycemic index natural foods improves blood glucose control and reduces the number of hypoglycemic events in type 1 diabetic patients. Diabetes Care October 2000 23:1461-1466; doi:10.2337/diacare.23.10.1461

  3. Parretti, E

    • What degree of maternal metabolic control in women with type 1 diabetes is associated with normal body size and proportions in full-term infants? Diabetes Care October 2000 23:1494-1498; doi:10.2337/diacare.23.10.1494

  4. Parsons, D

    • Skeletal muscle morphology and exercise response in congenital generalized lipodystrophy. Diabetes Care October 2000 23:1545-1550; doi:10.2337/diacare.23.10.1545

  5. Paschke, R

    • Improvement of insulin sensitivity after adrenalectomy in patients with pheochromocytoma. Diabetes Care October 2000 23:1591-1592; doi:10.2337/diacare.23.10.1591

  6. Peters, E J

    • Systemic hyperbaric oxygen therapy: lower-extremity wound healing and the diabetic foot. Diabetes Care October 2000 23:1551-1555; doi:10.2337/diacare.23.10.1551

  7. Pi-Sunyer, F X

    • Weight loss and mortality in type 2 diabetes. Diabetes Care October 2000 23:1451-1452; doi:10.2337/diacare.23.10.1451

R

  1. Rashid, S

    • Regarding depressive symptoms and metabolic control in African-Americans with type 2 diabetes. Diabetes Care October 2000 23:1596-1597; doi:10.2337/diacare.23.10.1596

  2. Rehman, S U

    • Regarding depressive symptoms and metabolic control in African-Americans with type 2 diabetes. Diabetes Care October 2000 23:1596-1597; doi:10.2337/diacare.23.10.1596

  3. Riccardi, G

    • Long-term dietary treatment with increased amounts of fiber-rich low-glycemic index natural foods improves blood glucose control and reduces the number of hypoglycemic events in type 1 diabetic patients. Diabetes Care October 2000 23:1461-1466; doi:10.2337/diacare.23.10.1461

  4. Rissanen, J

    • Variants in the hepatocyte nuclear factor-1alpha and -4alpha genes in Finnish and Chinese subjects with late-onset type 2 diabetes. Diabetes Care October 2000 23:1533-1538; doi:10.2337/diacare.23.10.1533

  5. Rivellese, A A

    • Long-term dietary treatment with increased amounts of fiber-rich low-glycemic index natural foods improves blood glucose control and reduces the number of hypoglycemic events in type 1 diabetic patients. Diabetes Care October 2000 23:1461-1466; doi:10.2337/diacare.23.10.1461

  6. Roller, R E

    • HbA1c determination and predicting the clinical status of diabetic patients. Diabetes Care October 2000 23:1597; doi:10.2337/diacare.23.10.1597

  7. Ryan, C M

    • Circumscribed cognitive dysfunction in middle-aged adults with type 2 diabetes. Diabetes Care October 2000 23:1486-1493; doi:10.2337/diacare.23.10.1486

  8. Ryan, M

    • Dietary unsaturated fatty acids in type 2 diabetes: higher levels of postprandial lipoprotein on a linoleic acid-rich sunflower oil diet compared with an oleic acid-rich olive oil diet. Diabetes Care October 2000 23:1472-1477; doi:10.2337/diacare.23.10.1472

S

  1. Sawin, C T

    • Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators. Diabetes Care October 2000 23:1478-1485; doi:10.2337/diacare.23.10.1478

  2. Scarselli, G

    • What degree of maternal metabolic control in women with type 1 diabetes is associated with normal body size and proportions in full-term infants? Diabetes Care October 2000 23:1494-1498; doi:10.2337/diacare.23.10.1494

  3. Schnedl, W J

    • HbA1c determination and predicting the clinical status of diabetic patients. Diabetes Care October 2000 23:1597; doi:10.2337/diacare.23.10.1597

  4. Seko, S

    • Association of autoimmune pancreatitis and type 1 diabetes: autoimmune exocrinopathy and endocrinopathy of the pancreas. Diabetes Care October 2000 23:1592-1594; doi:10.2337/diacare.23.10.1592

  5. Shakaib, A

    • Regarding depressive symptoms and metabolic control in African-Americans with type 2 diabetes. Diabetes Care October 2000 23:1596-1597; doi:10.2337/diacare.23.10.1596

  6. Silbert, C K

    • Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators. Diabetes Care October 2000 23:1478-1485; doi:10.2337/diacare.23.10.1478

  7. Stolk, R P

    • Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia. Diabetes Care October 2000 23:1467-1471; doi:10.2337/diacare.23.10.1467

  8. Stray-Gundersen, J

    • Skeletal muscle morphology and exercise response in congenital generalized lipodystrophy. Diabetes Care October 2000 23:1545-1550; doi:10.2337/diacare.23.10.1545

T

  1. Talbot, F

    • A review of the relationship between depression and diabetes in adults: is there a link? Diabetes Care October 2000 23:1556-1562; doi:10.2337/diacare.23.10.1556

  2. Taniguchi, T

    • Association of autoimmune pancreatitis and type 1 diabetes: autoimmune exocrinopathy and endocrinopathy of the pancreas. Diabetes Care October 2000 23:1592-1594; doi:10.2337/diacare.23.10.1592

  3. Targa, C

    • Diabetes is an independent risk factor for in-hospital mortality from acute spontaneous intracerebral hemorrhage. Diabetes Care October 2000 23:1527-1532; doi:10.2337/diacare.23.10.1527

  4. ter Braak, E W

    • Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia. Diabetes Care October 2000 23:1467-1471; doi:10.2337/diacare.23.10.1467

  5. Thompson, T J

    • Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care October 2000 23:1499-1504; doi:10.2337/diacare.23.10.1499

  6. Thun, M

    • Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care October 2000 23:1499-1504; doi:10.2337/diacare.23.10.1499

  7. Tomar, S L

    • Dental and other health care visits among U.S. adults with diabetes. Diabetes Care October 2000 23:1505-1510; doi:10.2337/diacare.23.10.1505

  8. Tomkin, G H

    • Dietary unsaturated fatty acids in type 2 diabetes: higher levels of postprandial lipoprotein on a linoleic acid-rich sunflower oil diet compared with an oleic acid-rich olive oil diet. Diabetes Care October 2000 23:1472-1477; doi:10.2337/diacare.23.10.1472

  9. Tuomilehto, J

    • Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care October 2000 23:1516-1526; doi:10.2337/diacare.23.10.1516

U

  1. Ueno, H

    • Association of autoimmune pancreatitis and type 1 diabetes: autoimmune exocrinopathy and endocrinopathy of the pancreas. Diabetes Care October 2000 23:1592-1594; doi:10.2337/diacare.23.10.1592

  2. Uusitupa, M

    • Variants in the hepatocyte nuclear factor-1alpha and -4alpha genes in Finnish and Chinese subjects with late-onset type 2 diabetes. Diabetes Care October 2000 23:1533-1538; doi:10.2337/diacare.23.10.1533

V

  1. van de Laak, M

    • Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia. Diabetes Care October 2000 23:1467-1471; doi:10.2337/diacare.23.10.1467

  2. van Haeften, T W

    • Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia. Diabetes Care October 2000 23:1467-1471; doi:10.2337/diacare.23.10.1467

  3. Vara, E

    • Intervention study for smoking cessation in diabetic patients: a randomized controlled trial in both clinical and primary care settings. Diabetes Care October 2000 23:1455-1460; doi:10.2337/diacare.23.10.1455

  4. Viik-Kajander, M

    • Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care October 2000 23:1516-1526; doi:10.2337/diacare.23.10.1516

W

  1. Wang, H

    • Variants in the hepatocyte nuclear factor-1alpha and -4alpha genes in Finnish and Chinese subjects with late-onset type 2 diabetes. Diabetes Care October 2000 23:1533-1538; doi:10.2337/diacare.23.10.1533

  2. Watkins, K W

    • Effect of adults' self-regulation of diabetes on quality-of-life outcomes. Diabetes Care October 2000 23:1511-1515; doi:10.2337/diacare.23.10.1511

  3. Williamson, D F

    • Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care October 2000 23:1499-1504; doi:10.2337/diacare.23.10.1499

  4. Windgassen, M

    • Improvement of insulin sensitivity after adrenalectomy in patients with pheochromocytoma. Diabetes Care October 2000 23:1591-1592; doi:10.2337/diacare.23.10.1591

  5. Wunderlich, R P

    • Systemic hyperbaric oxygen therapy: lower-extremity wound healing and the diabetic foot. Diabetes Care October 2000 23:1551-1555; doi:10.2337/diacare.23.10.1551

Z

  1. Zimmerman, B R

    • 2000 presidential address: American Diabetes Association. Diabetes Care October 2000 23:1581-1583; doi:10.2337/diacare.23.10.1581

Current Issue

  1. February 2012, 35 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes Care
Advertisement